Knee-Focused Non-Opioid Pain Relief
.png/:/rs=w:400,cg:true,m)
J'Neura Knee Pain PAtch
Anziva Pharmaceuticals is developing differentiated transdermal products for localized pain, starting with J’Neura™, a knee-specific patch designed for chronic knee pain.
Unlike general-purpose pain patches, J’Neura is being developed around the anatomy, movement, and treatment needs of the knee joint.
Status
Lead asset: J’Neura™ Knee Pain Patch
Stage: Pre-clinical development
Pathway: 505(b)(2) / OTC monograph strategy
Partnering focus: Licensing, co-development, commercialization, or strategic acquisition
Not Just Another Pain Patch
Most topical pain products are designed for broad use across the body. J’Neura is different.
J’Neura is being developed specifically for knee pain, with a patch design focused on localized delivery, flexibility, adhesion, and daily use around the knee joint.
The program is built around known analgesic pharmacology, differentiated formulation design, and a practical regulatory strategy.
Detailed formulation, active ingredient, comparative testing, IP, and development data are available under NDA.
About Us
About Us
About Us
Anziva Pharmaceuticals is built on a simple idea.
We don’t need new drugs for many problems.
We need to make existing ones work better.
We focus on reformulating proven therapies into products that perform better for patients in the real world.
Science
About Us
About Us
We build on what already works.
Using established regulatory pathways, we redesign known drugs into better delivery systems.
The goal is simple. Better performance. Faster path. Real outcomes.
PipeLine
About Us
PipeLine
We are building a focused pipeline in pain.
Starting with non opioid patches designed for real use.
Comfort, consistency, and targeted delivery.
Lead program: J’Neura knee pain patch